BONESUPPORT HOLDING AB (BOEUF)
32.50
0.00 (0.00%)
USD |
OTCM |
Oct 28, 16:00
BONESUPPORT Enterprise Value : 2.069B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 2.069B |
| October 27, 2026 | 2.069B |
| October 26, 2026 | 2.148B |
| October 23, 2026 | 2.069B |
| October 22, 2026 | 1.509B |
| October 21, 2026 | 1.509B |
| October 20, 2026 | 1.509B |
| October 19, 2026 | 1.509B |
| October 16, 2026 | 1.509B |
| October 15, 2026 | 1.509B |
| October 14, 2026 | 1.509B |
| October 13, 2026 | 1.509B |
| October 12, 2026 | 1.509B |
| October 09, 2026 | 1.450B |
| October 08, 2026 | 1.450B |
| October 07, 2026 | 1.450B |
| October 06, 2026 | 1.450B |
| October 05, 2026 | 1.450B |
| October 02, 2026 | 1.450B |
| October 01, 2026 | 1.450B |
| September 30, 2026 | 1.450B |
| September 29, 2026 | 1.445B |
| September 28, 2026 | 1.362B |
| September 25, 2026 | 1.362B |
| September 24, 2026 | 1.362B |
| Date | Value |
|---|---|
| September 23, 2026 | 1.362B |
| September 22, 2026 | 1.556B |
| September 21, 2026 | 1.556B |
| September 18, 2026 | 1.556B |
| September 17, 2026 | 1.556B |
| September 16, 2026 | 1.556B |
| September 15, 2026 | 1.556B |
| September 14, 2026 | 1.556B |
| September 11, 2026 | 1.556B |
| September 10, 2026 | 1.556B |
| September 09, 2026 | 1.556B |
| September 08, 2026 | 1.556B |
| September 04, 2026 | 1.556B |
| September 03, 2026 | 1.556B |
| September 02, 2026 | 1.494B |
| September 01, 2026 | 1.494B |
| August 31, 2026 | 1.494B |
| August 28, 2026 | 1.494B |
| August 27, 2026 | 1.494B |
| August 26, 2026 | 1.494B |
| August 25, 2026 | 1.494B |
| August 24, 2026 | 1.494B |
| August 21, 2026 | 1.494B |
| August 20, 2026 | 1.494B |
| August 19, 2026 | 1.538B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioInvent International AB | 183.41M |
| Swedish Orphan Biovitrum AB | 17.43B |
| Hansa Biopharma AB | 377.72M |
| BioArctic AB | 2.412B |
| Diamyd Medical AB | 87.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.569M |
| Revenue (Quarterly) | 42.36M |
| Total Expenses (Quarterly) | 32.79M |
| EPS Diluted (Quarterly) | 0.1441 |
| Gross Profit Margin (Quarterly) | 91.98% |
| Profit Margin (Quarterly) | 22.59% |
| Earnings Yield | 1.33% |
| Operating Earnings Yield | 1.74% |
| Normalized Earnings Yield | 1.298 |